Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

4D Molecular Therapeutics (FDMT) Preferred Shares Issued (2020)

4D Molecular Therapeutics (FDMT) has disclosed Preferred Shares Issued for 1 consecutive years, with -$32000.0 as the latest value for Q3 2020.

  • Quarterly Preferred Shares Issued changed N/A to -$32000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was -$32000.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $72.5 million for FY2020, 724780.0% up from the prior year.
  • Preferred Shares Issued for Q3 2020 was -$32000.0 at 4D Molecular Therapeutics.
  • The five-year high for Preferred Shares Issued was -$32000.0 in Q3 2020, with the low at -$32000.0 in Q3 2020.